Cargando…
Feasibility of Application of the Newly Developed Nano-Biomaterial, β-TCP/PDLLA, in Maxillofacial Reconstructive Surgery: A Pilot Rat Study
This study was performed to examine the applicability of the newly developed nano-biocomposite, β-tricalcium phosphate (β-TCP)/u-HA/poly-d/l-lactide (PDLLA), to bone defects in the oral and maxillofacial area. This novel nano-biocomposite showed several advantages, including biocompatibility, biodeg...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912080/ https://www.ncbi.nlm.nih.gov/pubmed/33503931 http://dx.doi.org/10.3390/nano11020303 |
_version_ | 1783656492923092992 |
---|---|
author | Toda, Erina Bai, Yunpeng Sha, Jingjing Dong, Quang Ngoc Ngo, Huy Xuan Suyama, Takashi Miyamoto, Kenichi Matsuzaki, Yumi Kanno, Takahiro |
author_facet | Toda, Erina Bai, Yunpeng Sha, Jingjing Dong, Quang Ngoc Ngo, Huy Xuan Suyama, Takashi Miyamoto, Kenichi Matsuzaki, Yumi Kanno, Takahiro |
author_sort | Toda, Erina |
collection | PubMed |
description | This study was performed to examine the applicability of the newly developed nano-biocomposite, β-tricalcium phosphate (β-TCP)/u-HA/poly-d/l-lactide (PDLLA), to bone defects in the oral and maxillofacial area. This novel nano-biocomposite showed several advantages, including biocompatibility, biodegradability, and osteoconductivity. In addition, its optimal plasticity also allowed its utilization in irregular critical bone defect reconstructive surgery. Here, three different nano-biomaterials, i.e., β-TCP/PDLLA, β-TCP, and PDLLA, were implanted into critical bone defects in the right lateral mandible of 10-week-old Sprague–Dawley (SD) rats as bone graft substitutes. Micro-computed tomography (Micro-CT) and immunohistochemical staining for the osteogenesis biomarkers, Runx2, osteocalcin, and the leptin receptor, were performed to investigate and compare bone regeneration between the groups. Although the micro-CT results showed the highest bone mineral density (BMD) and bone volume to total volume (BV/TV) with β-TCP, immunohistochemical analysis indicated better osteogenesis-promoting ability of β-TCP/PDLLA, especially at an early stage of the bone healing process. These results confirmed that the novel nano-biocomposite, β-TCP/PDLLA, which has excellent biocompatibility, bioresorbability and bioactive/osteoconductivity, has the potential to become a next-generation biomaterial for use as a bone graft substitute in maxillofacial reconstructive surgery. |
format | Online Article Text |
id | pubmed-7912080 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79120802021-02-28 Feasibility of Application of the Newly Developed Nano-Biomaterial, β-TCP/PDLLA, in Maxillofacial Reconstructive Surgery: A Pilot Rat Study Toda, Erina Bai, Yunpeng Sha, Jingjing Dong, Quang Ngoc Ngo, Huy Xuan Suyama, Takashi Miyamoto, Kenichi Matsuzaki, Yumi Kanno, Takahiro Nanomaterials (Basel) Article This study was performed to examine the applicability of the newly developed nano-biocomposite, β-tricalcium phosphate (β-TCP)/u-HA/poly-d/l-lactide (PDLLA), to bone defects in the oral and maxillofacial area. This novel nano-biocomposite showed several advantages, including biocompatibility, biodegradability, and osteoconductivity. In addition, its optimal plasticity also allowed its utilization in irregular critical bone defect reconstructive surgery. Here, three different nano-biomaterials, i.e., β-TCP/PDLLA, β-TCP, and PDLLA, were implanted into critical bone defects in the right lateral mandible of 10-week-old Sprague–Dawley (SD) rats as bone graft substitutes. Micro-computed tomography (Micro-CT) and immunohistochemical staining for the osteogenesis biomarkers, Runx2, osteocalcin, and the leptin receptor, were performed to investigate and compare bone regeneration between the groups. Although the micro-CT results showed the highest bone mineral density (BMD) and bone volume to total volume (BV/TV) with β-TCP, immunohistochemical analysis indicated better osteogenesis-promoting ability of β-TCP/PDLLA, especially at an early stage of the bone healing process. These results confirmed that the novel nano-biocomposite, β-TCP/PDLLA, which has excellent biocompatibility, bioresorbability and bioactive/osteoconductivity, has the potential to become a next-generation biomaterial for use as a bone graft substitute in maxillofacial reconstructive surgery. MDPI 2021-01-25 /pmc/articles/PMC7912080/ /pubmed/33503931 http://dx.doi.org/10.3390/nano11020303 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Toda, Erina Bai, Yunpeng Sha, Jingjing Dong, Quang Ngoc Ngo, Huy Xuan Suyama, Takashi Miyamoto, Kenichi Matsuzaki, Yumi Kanno, Takahiro Feasibility of Application of the Newly Developed Nano-Biomaterial, β-TCP/PDLLA, in Maxillofacial Reconstructive Surgery: A Pilot Rat Study |
title | Feasibility of Application of the Newly Developed Nano-Biomaterial, β-TCP/PDLLA, in Maxillofacial Reconstructive Surgery: A Pilot Rat Study |
title_full | Feasibility of Application of the Newly Developed Nano-Biomaterial, β-TCP/PDLLA, in Maxillofacial Reconstructive Surgery: A Pilot Rat Study |
title_fullStr | Feasibility of Application of the Newly Developed Nano-Biomaterial, β-TCP/PDLLA, in Maxillofacial Reconstructive Surgery: A Pilot Rat Study |
title_full_unstemmed | Feasibility of Application of the Newly Developed Nano-Biomaterial, β-TCP/PDLLA, in Maxillofacial Reconstructive Surgery: A Pilot Rat Study |
title_short | Feasibility of Application of the Newly Developed Nano-Biomaterial, β-TCP/PDLLA, in Maxillofacial Reconstructive Surgery: A Pilot Rat Study |
title_sort | feasibility of application of the newly developed nano-biomaterial, β-tcp/pdlla, in maxillofacial reconstructive surgery: a pilot rat study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912080/ https://www.ncbi.nlm.nih.gov/pubmed/33503931 http://dx.doi.org/10.3390/nano11020303 |
work_keys_str_mv | AT todaerina feasibilityofapplicationofthenewlydevelopednanobiomaterialbtcppdllainmaxillofacialreconstructivesurgeryapilotratstudy AT baiyunpeng feasibilityofapplicationofthenewlydevelopednanobiomaterialbtcppdllainmaxillofacialreconstructivesurgeryapilotratstudy AT shajingjing feasibilityofapplicationofthenewlydevelopednanobiomaterialbtcppdllainmaxillofacialreconstructivesurgeryapilotratstudy AT dongquangngoc feasibilityofapplicationofthenewlydevelopednanobiomaterialbtcppdllainmaxillofacialreconstructivesurgeryapilotratstudy AT ngohuyxuan feasibilityofapplicationofthenewlydevelopednanobiomaterialbtcppdllainmaxillofacialreconstructivesurgeryapilotratstudy AT suyamatakashi feasibilityofapplicationofthenewlydevelopednanobiomaterialbtcppdllainmaxillofacialreconstructivesurgeryapilotratstudy AT miyamotokenichi feasibilityofapplicationofthenewlydevelopednanobiomaterialbtcppdllainmaxillofacialreconstructivesurgeryapilotratstudy AT matsuzakiyumi feasibilityofapplicationofthenewlydevelopednanobiomaterialbtcppdllainmaxillofacialreconstructivesurgeryapilotratstudy AT kannotakahiro feasibilityofapplicationofthenewlydevelopednanobiomaterialbtcppdllainmaxillofacialreconstructivesurgeryapilotratstudy |